USE

XAI Octagon Floating Rate & Alternative Income Term Trust Will Host Q3 2023 Quarterly Webinar on November 30, 2023

Retrieved on: 
Monday, November 20, 2023
Consulting, Professional Services, Finance, Knowledge, NYSE, Investment, Egyptian Knowledge Bank, VIA, USE, Q&A, Eastern Time Zone, Trust, Online shopping

XAI Octagon Floating Rate & Alternative Income Term Trust (NYSE: XFLT) (the “Trust”) today announced that it plans to host the Trust’s Quarterly Webinar on November 30, 2023 at 10:30 am (Eastern Time).

Key Points: 
  • XAI Octagon Floating Rate & Alternative Income Term Trust (NYSE: XFLT) (the “Trust”) today announced that it plans to host the Trust’s Quarterly Webinar on November 30, 2023 at 10:30 am (Eastern Time).
  • Kimberly Flynn, Managing Director at XA Investments (“XAI”) will moderate the Q&A style webinar with Steven Perry, Vice President at XAI, and Gretchen Lam, Senior Portfolio Manager at Octagon Credit Investors.
  • The investment objective of the Trust is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.
  • Under normal market conditions, the Trust will invest at least 80% of its Managed Assets in floating rate credit instruments and other structured credit investments.

Clarion Partners Real Estate Income Fund Inc. Announces Funds from Operations

Retrieved on: 
Tuesday, November 14, 2023
Construction & Property, Professional Services, REIT, Finance, ACT, Franklin Templeton Investments, FAD, Clarion Partners, Bank statement, Investment, Depreciation, Public expenditure, USE, National Association, Trust, Tenant, GAAP, Real estate investment trust, FFO, Western Asset Management Company, FUTURE, AND, ALL, Real estate, Risk management, Bookkeeping, Fund

Clarion Partners Real Estate Income Fund Inc. (the “Fund”) has announced funds from operations (“FFO”), adjusted funds from operations and funds available for distribution for the period of January 1, 2023 to September 30, 2023.

Key Points: 
  • Clarion Partners Real Estate Income Fund Inc. (the “Fund”) has announced funds from operations (“FFO”), adjusted funds from operations and funds available for distribution for the period of January 1, 2023 to September 30, 2023.
  • FFO is a standard real estate investment trust (“REIT”) industry metric defined by the National Association of Real Estate Investment Trusts (“NAREIT”).
  • The Fund also believes that adjusted FFO (“AFFO”) is a meaningful non-GAAP supplemental disclosure of its operating results.
  • The Fund’s investment manager, Legg Mason Partners Fund Advisor, LLC, is an indirect, wholly-owned subsidiary of Franklin Resources, Inc. (“Franklin Resources”) and the Fund’s investment subadviser, Clarion Partners, LLC (“Clarion Partners”), is an indirect, majority-owned subsidiary of Franklin Resources.

New Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And Men

Retrieved on: 
Thursday, November 9, 2023
Yale School of Medicine, CAD, IV, Treatment, Coronary artery disease, Dissection, Doctor of Philosophy, IVL, Journal, St. Francis Hospital, TLF, MACE, HR, Perforation, CT, Woman, Safety, Society, USE, Hospital, Reflow soldering, EMPOWER, Cardiovascular disease, Pharmaceutical industry, Birth control, MD, Cardiology

The one-year results from Disrupt CAD III and IV trials were recently published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) .

Key Points: 
  • The one-year results from Disrupt CAD III and IV trials were recently published in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI) .
  • In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety and effectiveness in women and men at a one-year follow-up.
  • At one-year, major adverse cardiovascular event (MACE) rates were not different between women and men (12.3% vs 13.2%, p=0.52) and there was no difference between women and men in target lesion failure (TLF, 10.4% vs. 11.2% p=0.43).
  • The European lead is Nieves Gonzalo, MD, PhD, Consultant Interventional Cardiologist at Hospital Clinico San Carlos in Madrid, Spain.

Clarion Partners Real Estate Income Fund Inc. (CPREIF) Announces Tender Offer

Retrieved on: 
Thursday, November 9, 2023
Asset Management, Professional Services, Finance, ACT, Clarion Partners, FUTURE, Franklin Templeton Investments, Investment Company Act of 1940, Bank statement, Western Asset Management Company, Fund, AND, USE, ALL, FUND, Cryptocurrency

The tender offer will be conducted at a price equal to the Fund’s NAV per share of common stock on the day on which the tender offer expires.

Key Points: 
  • The tender offer will be conducted at a price equal to the Fund’s NAV per share of common stock on the day on which the tender offer expires.
  • The Fund intends to commence its tender offer on or about December 11, 2023, with the expiration of the tender offer currently expected to be January 11, 2024.
  • The tender offer will be made only by an Offer to Purchase, a Repurchase Request Form, and related documents.
  • As soon as the tender offer commences, the Fund will file a tender offer statement on Schedule TO with the SEC, which will include an Offer to Purchase and related Repurchase Request Form.

Jonathan Milner Issues Statement Responding to the Glass Lewis Report

Retrieved on: 
Monday, October 23, 2023
ACT, MAKE, ITS, TAX, FOR, PAST, FAIR, DATE, AS, UPDATE, SET, ANY, NO, AMERICA, FCA, EUROPEAN UNION, BY, FUTURE, FINANCIAL, III, TIME, UPON, NOT, EACH, AND, ALL, PER, THIS, OF, EXPRESS, AWARE, IS, NORTH, USE, IT, Glass fiber, Medical device, Audit, EU

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner Issues Statement Responding to ISS Report

Retrieved on: 
Monday, October 16, 2023
MAKE, ACT, III, AWARE, NO, AMERICA, NOT, PAST, TIME, DATE, THIS, AS, NORTH, USE, ANY, OF, IT, FOR, UPON, FINANCIAL, FCA, ITS, SET, IS, TAX, EXPRESS, EUROPEAN UNION, ALL, FAIR, UPDATE, BY, FUTURE, EACH, AND, Glass fiber, Medical device, Audit, EU

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company

Retrieved on: 
Monday, October 16, 2023
ACT, MAKE, III, AWARE, NO, AMERICA, NOT, PAST, TIME, DATE, THIS, AS, NORTH, USE, ANY, OF, IT, FOR, UPON, PER, FINANCIAL, FCA, ITS, SET, IS, TAX, EXPRESS, EUROPEAN UNION, ALL, FAIR, UPDATE, BY, FUTURE, EACH, AND, Glass fiber, Medical device, Audit, EU

DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.

Key Points: 
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER IS NOT RESPONSIBLE TO ANY PERSON FOR PROVIDING ADVICE IN RELATION TO THE SUBJECT MATTER OF THIS DOCUMENT.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Retrieved on: 
Tuesday, October 10, 2023
MAKE, ACT, III, AWARE, NO, AMERICA, NOT, PAST, TIME, DATE, THIS, AS, NORTH, USE, ANY, OF, IT, FOR, UPON, FINANCIAL, FCA, ITS, SET, IS, TAX, EXPRESS, EUROPEAN UNION, ALL, FAIR, UPDATE, BY, FUTURE, EACH, AND, Glass fiber, Medical device, Audit, EU

T: +44 7733 265 198 / E: [email protected]

Key Points: 
  • T: +44 7733 265 198 / E: [email protected]
    T: +44 (0)20 3709 5700 / E: [email protected]
    T: +1 646 677 1811 / E: [email protected]
    THIS DOCUMENT HAS BEEN ISSUED BY DR. JONATHAN MILNER ("DR. MILNER").
  • DR. MILNER STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION.
  • THE VIEWS EXPRESSED HEREIN REPRESENT THE OPINIONS OF DR. MILNER AS OF THE DATE HEREOF.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Clarion Partners Real Estate Income Fund Inc. Announces Results of Tender Offer

Retrieved on: 
Monday, October 16, 2023
Banking, Asset Management, Professional Services, Finance, ACT, Clarion Partners, Franklin Templeton Investments, Western Asset Management Company, Bank statement, Fund, SS, USE, FUTURE, Personal Information Agent, ALL, AND

The Fund will transmit payment to purchase the duly tendered and accepted Shares on or about October 16, 2023.

Key Points: 
  • The Fund will transmit payment to purchase the duly tendered and accepted Shares on or about October 16, 2023.
  • Shares that were tendered but not accepted for payment, if applicable, and Shares that were not tendered will remain outstanding.
  • Any questions about the tender offer should be directed to SS&C Global Investor & Distribution Solutions, Inc. (formerly SS&C Technologies, Inc.), the Information Agent for the tender offer, toll free at (844) 534-4627.
  • THIS PRESS RELEASE IS NOT A PROSPECTUS, CIRCULAR OR REPRESENTATION INTENDED FOR USE IN THE PURCHASE OR SALE OF FUND SHARES.

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Retrieved on: 
Tuesday, October 3, 2023
EUA, Heart, Pregnancy, Pharmacy, Caregiver, Tell, Arthralgia, Vaccination, Chills, Rite Aid, Infection, Fever, COVID-19, Center for Biologics Evaluation and Research, Coronavirus, Skin, Drug testing welfare recipients, Woman, COVID, Inflammation, Fact sheet, CVS Pharmacy, Government, CDC, Myalgia, Vomiting, Formula, Allergy, Physician, Child, XBB, Korea Disease Control and Prevention Agency, Immune system, USE, VAERS, Nausea, NVAX, European Medicines Agency, Ageing, FDA, Headache, Death, Regulation of tobacco by the U.S. Food and Drug Administration, FD, Food, World Health Organization, Fatigue, Pericarditis, Vaccine, Pharmaceutical industry, Birth control, Medical device, Mobile phone, Novavax COVID-19 vaccine, Hypoesthesia, Adjuvant, Novavax

In the coming days, individuals in the U.S. can go to pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine."

Key Points: 
  • In the coming days, individuals in the U.S. can go to pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine."
  • What should you mention to your vaccination provider before you or your child get the Novavax COVID-19 Vaccine, Adjuvanted?
  • A person should not get the Novavax COVID-19 Vaccine, Adjuvanted if they had:
    a severe allergic reaction after a previous dose of any Novavax COVID-19 Vaccine, Adjuvanted
    What are the risks of the Novavax COVID-19 Vaccine, Adjuvanted?
  • Women who are vaccinated with the Novavax COVID-19 Vaccine, Adjuvanted during pregnancy are encouraged to enroll in the registry by visiting https://c-viper.pregistry.com .